Cargando…
Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223407/ https://www.ncbi.nlm.nih.gov/pubmed/27456624 http://dx.doi.org/10.2337/db16-rt08 |
| _version_ | 1782493165002948608 |
|---|---|
| author | Berglund, Eric D. Lustig, Daniel G. Baheza, Richard A. Hasenour, Clinton M. Lee-Young, Robert S. Donahue, E. Patrick Lynes, Sara E. Swift, Larry L. Charron, Maureen J. Damon, Bruce M. Wasserman, David H. |
| author_facet | Berglund, Eric D. Lustig, Daniel G. Baheza, Richard A. Hasenour, Clinton M. Lee-Young, Robert S. Donahue, E. Patrick Lynes, Sara E. Swift, Larry L. Charron, Maureen J. Damon, Bruce M. Wasserman, David H. |
| author_sort | Berglund, Eric D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5223407 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52234072017-01-12 Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 Berglund, Eric D. Lustig, Daniel G. Baheza, Richard A. Hasenour, Clinton M. Lee-Young, Robert S. Donahue, E. Patrick Lynes, Sara E. Swift, Larry L. Charron, Maureen J. Damon, Bruce M. Wasserman, David H. Diabetes Statement of Retraction American Diabetes Association 2016-08 2016-07-12 /pmc/articles/PMC5223407/ /pubmed/27456624 http://dx.doi.org/10.2337/db16-rt08 Text en © 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
| spellingShingle | Statement of Retraction Berglund, Eric D. Lustig, Daniel G. Baheza, Richard A. Hasenour, Clinton M. Lee-Young, Robert S. Donahue, E. Patrick Lynes, Sara E. Swift, Larry L. Charron, Maureen J. Damon, Bruce M. Wasserman, David H. Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title | Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title_full | Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title_fullStr | Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title_full_unstemmed | Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title_short | Statement of Retraction. Hepatic Glucagon Action Is Essential for Exercise-Induced Reversal of Mouse Fatty Liver. Diabetes 2011;60:2720–2729. DOI: 10.2337/db11-0455 |
| title_sort | statement of retraction. hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver. diabetes 2011;60:2720–2729. doi: 10.2337/db11-0455 |
| topic | Statement of Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223407/ https://www.ncbi.nlm.nih.gov/pubmed/27456624 http://dx.doi.org/10.2337/db16-rt08 |
| work_keys_str_mv | AT berglundericd statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT lustigdanielg statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT bahezaricharda statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT hasenourclintonm statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT leeyoungroberts statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT donahueepatrick statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT lynessarae statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT swiftlarryl statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT charronmaureenj statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT damonbrucem statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 AT wassermandavidh statementofretractionhepaticglucagonactionisessentialforexerciseinducedreversalofmousefattyliverdiabetes20116027202729doi102337db110455 |